ARMP · Armata Pharmaceuticals, Inc.
$4.56
-0.26 (-5.39%)
At close · Aug 14
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. While management believes this plan to raise additional funds will alleviate the conditions that raise substantial doubt, these plans are not entirely within our control and cannot be assessed as being probable of occurring.”View the 10-Q filed Aug 12, 2026
Market Cap
$169.55M
Shares
37.18M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-12 | — | |
| 10-Q | 2026-08-12 | 2026-06-30 | |
| 8-K | 2026-07-20 | — | |
| 8-K | 2026-07-20 | 2026-07-17 | |
| 8-K | 2026-07-13 | — | |
| 8-K/A | 2026-06-24 | 2026-04-24 | |
| 8-K | 2026-06-23 | — | |
| 8-K | 2026-06-16 | 2026-06-11 | |
| 10-Q | 2026-05-13 | 2026-03-31 | |
| 8-K | 2026-05-13 | 2026-05-12 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-27 | 2026-06-11 | |
| 8-K | 2026-04-27 | 2026-04-24 | |
| 8-K | 2026-04-02 | — | |
| 8-K | 2026-03-25 | — | |
| 10-K | 2026-03-25 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2026-01-26 | — | |
| 8-K | 2026-01-13 | — | |
| 8-K | 2025-12-01 | — | |
| 8-K | 2025-11-12 | — | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-10-22 | — | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 8-K | 2025-08-12 | 2025-08-11 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-13 | 2025-06-12 | |
| 8-K | 2025-05-19 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-05-01 | — | |
| DEF 14A | 2025-04-28 | 2025-06-12 | |
| 8-K | 2025-04-02 | — | |
| 10-K | 2025-03-21 | 2024-12-31 | |
| 8-K | 2025-03-21 | 2025-03-20 | |
| 8-K | 2025-03-12 | — | |
| 8-K | 2024-12-19 | — | |
| 8-K | 2024-12-04 | 2024-12-02 | |
| 8-K | 2024-11-15 | 2024-11-12 | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-10-03 | 2024-09-30 | |
| 8-K | 2024-09-26 | 2024-09-22 | |
| 8-K | 2024-08-26 | — | |
| 8-K | 2024-08-15 | 2024-07-31 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-07-25 | 2024-07-22 |
Showing 1–50 of 120 filings
Key facts
CIK
921114
CUSIP
04216R102
13F (30d)
51 filings
51 filers
Visit website
Investor relations